Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
Clinical and Molecular Hepatology. 2020;26(4):705-714 
Chronic Liver Disease and COVID‐19: Alcohol Use Disorder/Alcohol‐Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis
Clinical Liver Disease. 2020;15(5):195-199
Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers
Clinical Liver Disease. 2012;1(4):104-107
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Clinical Liver Disease. 2018;11(4):81-81
Management of nonalcoholic fatty liver disease in children
Clinical Liver Disease. 2012;1(4):129-130
Non-coding RNAs Related to Lipid Metabolism and Non-alcoholic Fatty Liver Disease
Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer. 2021;73-88
Management of Nonalcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018;
Natural history of nonalcoholic fatty liver disease
Clinical Liver Disease. 2012;1(4):112-113
Insulin Therapy and Autoimmune Disease with Relevance to Non Alchoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease - An Update. 2019;
Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and management
Clinical Liver Disease. 2012;1(4):125-128